1 / 26

LEPTOSPIROSIS: The “Other” Spirochete

LEPTOSPIROSIS: The “Other” Spirochete. UNM Marine and Tropical Medicine April, 2005. Lecture Overview. Epidemiology and Vectors of Lepto Clinical and Laboratory Findings Weil’s Disease Making the Diagnosis Prevention and Treatment Morbidity and Mortality. Learning Objectives.

douglasy
Télécharger la présentation

LEPTOSPIROSIS: The “Other” Spirochete

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. LEPTOSPIROSIS: The “Other” Spirochete UNM Marine and Tropical Medicine April, 2005

  2. Lecture Overview • Epidemiology and Vectors of Lepto • Clinical and Laboratory Findings • Weil’s Disease • Making the Diagnosis • Prevention and Treatment • Morbidity and Mortality

  3. Learning Objectives • Know the risk factors associated with Leptospirosis. • Know the common clinical and laboratory findings associated with Lepto. • Know the prevention and treatment options for Lepto.

  4. Lepto: World Wide Epidemiology • Most common illness transmitted by animals. (zoonosis) • Occurs everywhere except the polar regions. Most common in the tropics • Hot spots: Belize, Tahiti, Thailand, Vietnam. • In the US: sporadic epidemics, usually recreation related

  5. Lepto: Hawaiian Epidemiology • Hawaii: Endemic. Highest prevalence in the US with incidence ~ 128/100,000 annually • Population of the Big Island in 2002: 148,677 • We would expect ~190 symptomatic cases per year on the island

  6. Hawaii: all the right conditions • The spirochete prefers warm moist environments and a rodent reservoir • The two hot spots on the islands are Kauai and the East side of the Big Island

  7. Hawaii: the reservoir (dogs)

  8. Animal Vectors

  9. Leptospirosis in the Urine • Infected animals can shed spirochetes in their urine for years. Lepto remains in the renal tubules. • Infected humans can shed spirochetes in their urine for up to 60 days. We are considered accidental hosts.

  10. Hawaiian Risk Factors • Rainwater catchment systems • Contact with cattle • Handling of animal tissue

  11. Hawaii: a familiar sign

  12. Making the diagnosis • Maintaining an index of suspicion: • Practicing in an endemic area • Patient with travel to an endemic area • Maintaining an index of suspicion in the face of nonspecific clinical findings and test results

  13. Clinical Features • Sudden onset (high) fever • Dry cough, severe headache, sore throat • Myalgias • Most cases are probably self limited (~90%) and many people do not seek treatment

  14. Clinical Findings • Suffusion- peripheral engorgement of conjunctival vessels. • Icterus

  15. Laboratory Features • Mild leukocytosis • Mild to moderate thrombocytopenia • ESR elevated >50 mm/hr • Mild elevations of LFTs, lipase • Elevated CPKs • Proteinuria • CSF: similar to aseptic meningitis • CXR: B/L nonlobar peripheral consolidations

  16. Typical CXR

  17. Making the Diagnosis • UCxs are the most likely to become positive. • Blood/tissue cultures can be difficult: lepto requires a special medium and can take months to become positive. • ELISA and MAT (microscopic agglutination) are used, but can give false negatives early on in disease course. • It’s a clinical diagnosis

  18. An infectious disease expert’s smorgasbord of favorites… Dengue fever Hanta virus Viral hemorrhagic fevers (Ebola, Marburg) Influenza Typhoid fever Rickettsial diseases Brucellosis Differential Diagnosis

  19. Pathophysiology • The spirochetes are thought to multiply within capillary endothelium causing a vasculitis. • This occurs in almost any and all tissues. • Kidneys, lung, muscle, liver, brain, heart etc.

  20. The Severe Form: Weil’s Disease • Renal Failure – may require dialysis • Liver dysfunction – rarely progresses to liver failure • Thrombocytopenia -> DIC • Pulmonary hemorrhage and ARDS • Myocarditis -> CHF • Encephalitis

  21. CXR in Weil’s Disease

  22. Predicting Severe Disease • It appears to be impossible to predict whose illness will progress to a fulminate course vs. a self limited illness.

  23. Mortality • Mortality rates are reported as 5-40% worldwide. Hawaii has the lowest mortality rate even for severe forms of the disease. • Most of the deaths are in areas that lack critical care capabilities (the 3rd World)

  24. Prevention • High risk travelers can take prophylactic doxycycline (covers malaria, too. • A vaccine is available in SE Asia and Europe. • Vaccine has uncertain efficacy and safety. • Consider for people in high risk jobs: rice paddy workers, sugar cane & banana plantation workers, folks working with animals in endemic areas.

  25. Treatment • PCN – Jarisch-Herxheimer reaction has been reported • Doxycycline • 3rd generation Cephalosporin • Because the diagnosis may not be certain early on, starting with broad spectrum coverage is reasonable. • Efficacy of steroids has not been established.

  26. Lepto: Reportable • Although the feds don’t require reporting of lepto, every state DOH I checked does…CA, HI, NM, PA, MN • It is probably underreported because of the difficulty in confirming the diagnosis.

More Related